Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?

被引：0
|
作者：
Kim, S. [1 ]
Kang, D. H. [1 ,2 ]
Lee, J. H.
Cho, W. S. [1 ]
Jeung, Y. I. [1 ]
Park, J. H. [2 ]
Jeung, K. S. [3 ]
机构：
[1] Pusan Natl Univ, Yangsan Hosp, Pusan, South Korea
[2] Pusan Bongsaeng Hosp, Pusan, South Korea
[3] Jinju Korea Hosp, Jinju, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：196 / 197
页数：2
相关论文
共 50 条
  • [31] Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial
    Cheon, Young Koog
    Cho, Kwang Bum
    Watkins, James L.
    McHenry, Lee
    Fogel, Evan L.
    Sherman, Stuart
    Schmidt, Suzette
    Lazzell-Pannell, Laura
    Lehman, Glen A.
    GASTROINTESTINAL ENDOSCOPY, 2007, 66 (06) : 1126 - 1132
  • [32] A Single-Center Experience With the Prevention of Post-ERCP Pancreatitis by the Use of Rectal Indomethacin in a High-Risk Population
    Rubinov, Jason
    Kutner, Matthew
    Broder, Arkady
    D'Souza, Lionel
    Ascunce, Gil
    Carr-Locke, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S88 - S88
  • [33] EFFICACY OF PROPHYLACTIC USE OF LOW-DOSE INDOMETHACIN IN REDUCING POST-ERCP PANCREATITIS IN HIGH-RISK POPULATION
    Yalikong, Ayimukedisi
    Qi, Zhipeng
    Chen, Zhanghan
    He, Dongli
    Zhou, Pinghong
    Zhong, Yunshi
    GASTROINTESTINAL ENDOSCOPY, 2023, 97 (06) : AB583 - AB583
  • [34] Rectal diclofenac does not prevent post-ERCP pancreatitis in consecutive high-risk and low-risk patients
    Lourdes del-Olmo-Martinez, M.
    Velayos-Jimenez, Benito
    Almaraz-Gomez, Ana
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2018, 110 (08) : 505 - 509
  • [35] Endoscopic Pancreatic Stent for Prophylaxis in Patients at High-Risk of Post-ERCP Pancreatitis: A Matched Propensity Analysis
    Hayashi, Shiro
    Nishida, Tsutomu
    Shimakoshi, Hiromi
    Shimoda, Akiyoshi
    Amano, Takahiro
    Sakamoto, Aisa
    Otake, Yuriko
    Sugimoto, Aya
    Takahashi, Kei
    Mukai, Kaori
    Matsubara, Tokuhiro
    Yamamoto, Masashi
    Nakajima, Sachiko
    Fukui, Koji
    Inada, Masami
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB273 - AB273
  • [36] Prophylasix of Post-ERCP Pancreatitis With Nafamostat Mesilate: Comparison of 24-Hour and 8-Hour Infusion of Nafamostat Mesilate: a Prospective Randomized Comparison Trial
    Kim, Wan Chul
    Jeon, Joon Ho
    Shin, Jae Gyu
    Nam, Hyeong Seok
    Kang, Dae Hwan
    Kim, Hyung Wook
    Choi, Cheol Woong
    Park, Su Bum
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB160 - AB160
  • [37] Prevention of post-ercp pancreatitis by using nafamostat mesilate: comparison of 8-hour infusion versus 24-hour infusion
    Choi, Yu Yi
    Kang, Dae Hwan
    Choi, Cheol Woong
    Park, Su Bum
    Hong, Joung Boom
    Kim, Dong Jun
    Shin, Young Shin
    Kang, Dong Ku
    Kim, Min Dae
    Jeong, Eul Jo
    Kim, Hyung Wook
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 138 - 138
  • [38] Incidence, risk factors, and prevention of post-ERCP pancreatitis
    Cooper, Scott T.
    Slivka, Adam
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2007, 36 (02) : 259 - +
  • [39] Prophylactic Rectal Indomethacin and Prophylactic Pancreatic Duct Stents (PPS) for Prevention of Post-ERCP Pancreatitis Are Underutilized in Average and High-Risk Patients Undergoing ERCP
    Issak, Abdulfatah
    Elangovan, Abbinaya
    Ferguson, Roy
    Waghray, Nisheet
    Sandhu, Dalbir S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S39 - S39
  • [40] NAFAMOSTAT MESILATE - A REGIONAL ANTICOAGULANT FOR HEMODIALYSIS IN PATIENTS AT HIGH-RISK FOR BLEEDING
    AKIZAWA, T
    KOSHIKAWA, S
    OTA, K
    KAZAMA, M
    MIMURA, N
    HIRASAWA, Y
    NEPHRON, 1993, 64 (03): : 376 - 381
12345